rs1296023

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The ENST00000534382.6(CTSB):​c.-457T>C variant causes a 5 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.325 in 149,306 control chromosomes in the GnomAD database, including 7,936 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.33 ( 7929 hom., cov: 27)
Exomes 𝑓: 0.35 ( 7 hom. )

Consequence

CTSB
ENST00000534382.6 5_prime_UTR

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: 0.339

Publications

18 publications found
Variant links:
Genes affected
CTSB (HGNC:2527): (cathepsin B) This gene encodes a member of the C1 family of peptidases. Alternative splicing of this gene results in multiple transcript variants. At least one of these variants encodes a preproprotein that is proteolytically processed to generate multiple protein products. These products include the cathepsin B light and heavy chains, which can dimerize to form the double chain form of the enzyme. This enzyme is a lysosomal cysteine protease with both endopeptidase and exopeptidase activity that may play a role in protein turnover. It is also known as amyloid precursor protein secretase and is involved in the proteolytic processing of amyloid precursor protein (APP). Incomplete proteolytic processing of APP has been suggested to be a causative factor in Alzheimer's disease, the most common cause of dementia. Overexpression of the encoded protein has been associated with esophageal adenocarcinoma and other tumors. Both Cathepsin B and Cathepsin L are involved in the cleavage of the spike protein from the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) upon its entry to the human host cell. Multiple pseudogenes of this gene have been identified. [provided by RefSeq, Sep 2020]
CTSB Gene-Disease associations (from GenCC):
  • keratolytic winter erythema
    Inheritance: AD Classification: STRONG, LIMITED Submitted by: Labcorp Genetics (formerly Invitae), G2P, Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.9).
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.469 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
CTSBENST00000534382.6 linkc.-457T>C 5_prime_UTR_variant Exon 1 of 10 4 ENSP00000435260.2 P07858E9PKX0
CTSBENST00000677671.1 linkc.-412T>C 5_prime_UTR_variant Exon 1 of 10 ENSP00000503578.1 P07858

Frequencies

GnomAD3 genomes
AF:
0.325
AC:
48500
AN:
149110
Hom.:
7930
Cov.:
27
show subpopulations
Gnomad AFR
AF:
0.318
Gnomad AMI
AF:
0.422
Gnomad AMR
AF:
0.305
Gnomad ASJ
AF:
0.216
Gnomad EAS
AF:
0.484
Gnomad SAS
AF:
0.367
Gnomad FIN
AF:
0.356
Gnomad MID
AF:
0.281
Gnomad NFE
AF:
0.320
Gnomad OTH
AF:
0.312
GnomAD4 exome
AF:
0.347
AC:
34
AN:
98
Hom.:
7
Cov.:
0
AF XY:
0.368
AC XY:
28
AN XY:
76
show subpopulations
African (AFR)
AF:
0.250
AC:
1
AN:
4
American (AMR)
AF:
0.00
AC:
0
AN:
2
Ashkenazi Jewish (ASJ)
AC:
0
AN:
0
East Asian (EAS)
AF:
0.500
AC:
1
AN:
2
South Asian (SAS)
AC:
0
AN:
0
European-Finnish (FIN)
AC:
0
AN:
0
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
4
European-Non Finnish (NFE)
AF:
0.350
AC:
28
AN:
80
Other (OTH)
AF:
0.667
AC:
4
AN:
6
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.492
Heterozygous variant carriers
0
1
3
4
6
7
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.325
AC:
48532
AN:
149208
Hom.:
7929
Cov.:
27
AF XY:
0.327
AC XY:
23764
AN XY:
72686
show subpopulations
African (AFR)
AF:
0.318
AC:
12836
AN:
40414
American (AMR)
AF:
0.305
AC:
4578
AN:
15022
Ashkenazi Jewish (ASJ)
AF:
0.216
AC:
748
AN:
3458
East Asian (EAS)
AF:
0.485
AC:
2413
AN:
4976
South Asian (SAS)
AF:
0.366
AC:
1729
AN:
4722
European-Finnish (FIN)
AF:
0.356
AC:
3556
AN:
9998
Middle Eastern (MID)
AF:
0.275
AC:
77
AN:
280
European-Non Finnish (NFE)
AF:
0.320
AC:
21569
AN:
67376
Other (OTH)
AF:
0.314
AC:
648
AN:
2066
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.500
Heterozygous variant carriers
0
1575
3151
4726
6302
7877
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
494
988
1482
1976
2470
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.317
Hom.:
27800
Bravo
AF:
0.318
Asia WGS
AF:
0.413
AC:
1436
AN:
3476

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.90
CADD
Benign
3.5
DANN
Benign
0.56
PhyloP100
0.34
PromoterAI
0.010
Neutral

Splicing

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs1296023; hg19: chr8-11726817; API